Office of Technology Development

Office of Technology Development: Technologies Available for Licensing

Memorial Sloan-Kettering is developing an extensive assortment of technologies with applications for oncology and many other areas of healthcare and science. We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.

Explore our list of technologies available for licensing below, and filter by technology categories.

Some of our newest technologies may not appear in this list. To learn about recent developments, contact any member of our staff about your particular interests.

Filter these technologies
Clear
Showing 1 - 20 of 85 technologies
2-[18F]-Labeled Compounds and PET Imaging of Tumors for Enhanced Diagnostic and Therapeutic Monitoring Purposes [SK1365]
Animal studies
Types: Diagnostics: Imaging
Indications: Indications: Cancer
A Novel and Efficient Method for Fat-Free Nuclear Magnetic Imaging [SK1302]
Ready to use
Types: Diagnostics: Imaging; Software/Algorithm
Indications: Indications: Cancer; Indications: Inflammatory/Immune Disease
Acid Sphingomyelinase: A New Drug Target to Regulate Apoptosis [SK 737]
Ready to use
Types: Research Tools: Assays; Research Tools: Screening Technologies
Indications: Indications: Cancer; Indications: Inflammatory/Immune Disease; Indications: Neurologic Disease
An Improved Apparatus for One-Lung Isolation [SK1063]
Design/Prototype
Types: Devices: Surgical
Analogs of Actinonin as Antitumor Compounds [SK 934]
In vitro
Types: Therapeutics: Natural products; Therapeutics: Small molecules
Indications: Indications: Cancer
Apparatus that Facilitates Cell Growth and Screening under Variable Hydrostatic Pressures [SK1017]
Ready to use
Types: Research Tools; Research Tools: Laboratory Devices
Indications: Indications: Cancer
Apparatus that Improves Optics in Multi-Photon Laser Scanning Microscopes [SK 951]
Ready to use
Types: Devices: Microscopy
Caki-1: Human Renal Cancer Cell Line [SK1980-534 ]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Urinary System
Caki-2: Human Renal Cancer Cell Line [SK2010-068]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Urinary System
Calu-1: Human Lung Cancer Cell Line [SK 784]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Lung
Calu-3: Human Lung Cancer Cell Line [SK1980-533]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Lung
CAMA-1: Human Breast Cancer Cell Line [SK 926]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Breast
Cancer Diagnosis and Prognosis by Determining Levels of MDM2 and p53 and Antibodies Against MDM2 [SK 596]
Ready to use
Types: Diagnostics: Tissue diagnostics
Indications: Indications: Cancer
Cancer Marker Discovery and Validation [SK1181]
Clinical development
Types: Diagnostics: Biomarkers; Diagnostics: Molecular diagnostics
Indications: Indications: Cancer
Caov-3 : Human Ovarian Cancer Cell Line [SK2010-069]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Ovarian
Caov-4 : Human Ovarian Cancer Cell Line [SK2010-070]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Ovarian
Capan-1: Human Pancreatic Adenocarcinoma Cell Line [SK 923]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Pancreatic
Capan-2: Human Pancreatic Adenocarcinoma Cell Line [SK2000-049]
Ready to use
Types: Research Tools: Cell Lines
Indications: Cancer: Pancreatic
Cathepsin Inhibitor Combined Therapy Provides Enhanced Treatment of Solid Tumors [SK1326]
Animal studies
Types: Therapeutics: Small molecules
Indications: Indications: Cancer
Chimeric Antigen Receptors for Adoptive Cell Therapy [SK1036/SK1276]
Types: Therapeutics: Cell/Gene therapies
Indications: Indications: Cancer

The Office of
Technology Development

Our 2013 work to date
68Invention Disclosures
118Patent Applications
25Patents Issued